Newstral
Article
jdsupra.com on 2015-11-13 20:20
Patent Infringement Safe Harbor and Importation Redefined: Ruling Incentivizes Generic Pharmaceutical Offshore Product Testing
Related news
- ITC Finds Violation Based on Infringement of Method Claim After Importationjdsupra.com
- Court Denies Generic Drug Manufacturer’s Motion to Dismiss Hatch-Waxman Patent Infringement Action on Jurisdiction Groundsjdsupra.com
- Despite the pharmaceutical industry claims, illicit drug shipments to US aren’t full of opioids. It’s generic Viagra.San Jose Mercury News
- DOJ Catches Big Fish in Generic Pharmaceutical Criminal Antitrust Investigationjdsupra.com
- Skinny Labelling on Generic Drugs Does Not Avoid Induced Infringement of Patents Covering Non-Indicated Usesjdsupra.com
- Filing an ANDA May Expose Generic Manufacturers to Nationwide Personal Jurisdiction in Patent Infringement Suitsjdsupra.com
- Labeling carve-out does not shield generic drug makers from induced infringement claims, CAFC rulesjdsupra.com
- U.S. states allege broad generic drug price-fixing collusion, triggering fall in pharmaceutical stocksThe Japan Times
- Update on Pending Legislation: Three New Bills Have the Potential to Affect Generic Pharmaceutical Companiesjdsupra.com
- Sale of Generic Drug to Physician With “Extensive Information” on the Label May Induce Infringementjdsupra.com
- Omeros sues Par Pharmaceutical to block generic version of first drugbizjournals.com
- Tracking the backlash when pharmaceutical firms hike up generic drug pricesbangordailynews.com
- ALJ Shaw Confirms ITC’s Post-Suprema Authority to Exclude Articles That Infringe After Importation Based on Contributory Infringementjdsupra.com
- Federal Circuit Case May Diminish the Ability of Generic Drug Makers to Avoid Induced Infringement by Skinny Labelingjdsupra.com
- Teva Pharmaceutical Industries to buy Allergan Plc’s generic drug business for US$40.5 billion, drops Mylan bidbusiness.financialpost.com
- District Court Case Highlights Nuances Associated with Determining If a Generic or Biosimilar Applicant Is Entitled to Protection of the Non-Infringement Safe Harborjdsupra.com
- U.S. Government Patent Infringement Precludes Induced Infringementjdsupra.com
- Burlesque, RedefinedThe New York Times
- Generic Drug Labeling and Induced Patent Infringementjdsupra.com
- FDA approves 1st generic EpiPenwbrc.com